D53.1
Other megaloblastic anemias, not elsewhere classified
Clinical Classification Guidelines
Inclusion Terms
- Megaloblastic anemia NOS
Excludes Type 1
- Di Guglielmo's disease (C94.0)
Medical Intelligence & Overview
Megaloblastic anemia is a blood disorder characterized by the production of unusually large, immature, and dysfunctional red blood cells. When the condition doesn't fall into more specific categories, it is classified under ICD-10 code D53.1, known as 'Other megaloblastic anemias, not elsewhere classified.' This form of anemia can result from various nutritional deficiencies or other underlying health issues. It affects the body's ability to produce healthy red blood cells, leading to symptoms of anemia and related health concerns.
Causes & Symptoms
Clinical Causes: Deficiency of vitamin B12 (cobalamin) Folate deficiency, either due to inadequate dietary intake or absorption issues Certain medications such as anticonvulsants or methotrexate that interfere with vitamin absorption Alcohol abuse, which impair nutrient absorption Malabsorption syndromes like celiac disease or Crohn's disease Rare genetic disorders affecting DNA synthesis
Key Symptoms: Fatigue and weakness Pale or jaundiced skin Shortness of breath Dizziness or lightheadedness Rapid heartbeat Sore tongue or mouth ulcers Nerve-related issues like numbness or tingling in extremities Memory problems or difficulty concentrating
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood tests, including a complete blood count (CBC) to observe cell size and hemoglobin levels, vitamin B12 and folate level assessments to identify deficiencies, and peripheral blood smear examinations. Additional tests such as bone marrow biopsies may be used to evaluate blood cell production and rule out other bone marrow disorders. Identifying the underlying cause is crucial for appropriate treatment.
Treatment Protocols: Treatment strategies aim to correct nutritional deficiencies and address underlying causes. This often involves supplementation with vitamin B12 injections or oral folic acid. In cases caused by malabsorption syndromes, managing the underlying disease is essential. Regular monitoring of blood counts and vitamin levels is necessary to ensure recovery and prevent recurrence. Addressing lifestyle factors like alcohol consumption and medication use may also be part of the treatment plan.
Clinical Advice & FAQs
Billing Guidance
Is D53.1 a billable ICD-10 code?
Yes, D53.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D53.1?
Clinical documentation must specify the nature of Other megaloblastic anemias, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference